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Background: The use of antimicrobial solutions has been recommended to disinfect demineralized dentin prior to
placing the filling material. The aim of this study was to evaluate the ability of several antimicrobials in controlling
Streptococcus mutans (SM) biofilm formed in dentin.
Methods: Antimicrobial activity of 0.2% and 2% chlorhexidine (CHX), 0.2% cetrimide (CTR) and 0.2%, 0.5%, 1% and
2% alexidine (ALX) was assayed on 1-week SM biofilm formed on standardized coronal dentin blocks. Results of SM
biofilm antimicrobial activity by different protocols were expressed as the kill percentage of biofilm and the term
“eradication” was used to denote the kill of 100% of the bacterial population. To compare the efficacies of the
different protocols the Student t test was used, previously subjecting data to the Anscombe transformation.
Results: All ALX concentrations tested and 0.2% CTR achieved a kill percentage higher than 99%, followed by 2%
CHX with percentages above 96% (no statistically significant difference among them). Whereas 2% ALX and 0.2%
CTR respectively showed eradication in 10 and 9 of the twelve specimens, 0.2% CHX did not produce eradication in
any case.
Conclusions: The present study shows that, when used for one minute, 2% and 1% alexidine, and 0.2% cetrimide,
achieve eradication of Streptococcus mutans biofilm in most specimens when applied to a dentin-volumetric model.
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Dental caries is a chronic and transmissible disease char-
acterized by demineralization of the tooth due to acids
produced by bacteria in biofilms formed on its surface.
Streptococcus mutans (SM) is considered one of the
most cariogenic bacteria present in human dental bio-
film [1] and in dentin caries lesions [1-3]. Its metabolic
activity is closely related to the initiation and progression
of dental caries [2].
The treatment of deep caries lesions has traditionally
involved removal of all the soft demineralized dentin
before a filling is placed. However, operative dentistry is
now moving away from complete caries removal to an* Correspondence: matr@ugr.es
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article, unless otherwise stated.ultraconservative approach, preserving tooth structure
and preventing pulpal injury [3]. Clinical procedures in-
volving incomplete caries removal are advocated based on
the concept that deep carious dentin lesions comprise two
distinct layers: an outer layer or infected dentin, highly
contaminated and not recoverable, and an inner layer
of affected dentin —less frequently contaminated with
bacteria and preserving the cross-banded ultra structure
of the collagen matrix— capable of being remineralized.
Within this context, the objective of partial caries removal
is to eliminate only superficial carious dentin that is highly
infected, whereas dentin able to remineralize is main-
tained [4].
Microbiological and clinical studies have shown that the
number of bacteria decreases during incomplete carious
removal followed by adequate cavity sealing, and that
lesions are clinically arrested [5-10]. Although a limitedntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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few months after the partial caries removal and sealing
[5,8,9], some cariogenic bacteria may be found within the
remaining microorganisms, such as Streptococcus mutans,
which is currently found on sealed carious dentin [2,6-9].
Moreover, it has recently been reported that the genotypic
diversity of SM decreased after partial dentin removal
and sealing, whereas the virulence traits of SM were un-
changed, maintaining the same cariogenic potential [9].
In this context, efforts to eliminate or reduce residual
bacteria in affected dentin aiming to decrease the risk of
caries progression persist. Among possible strategies, anti-
microbial solutions have been recommended to clean the
cavity prior to introducing the filling material [10]. Of all
available antimicrobials in dentistry, chlorhexidine (CHX)
is still the most frequently used agent to reduce plaque
aiming at caries control [11]. CHX is widely used as an
antimicrobial agent for disinfection before the placement
of restorations [10,12]. It has demonstrated its effective-
ness against bacteria associated with dental caries, and SM
has been shown to be particularly sensitive to CHX [13].
Due to its broad antimicrobial spectrum (i.e. against gram
positive/negative bacteria and fungi), CHX has been used
to adjunctively treat either endodontic or periodontal
diseases and to arrest/prevent caries progression [11]. At
the concentrations used clinically, the biocompatibility of
CHX is acceptable having a low degree of toxicity [14]. In
dentin samples with bacterial biofilm, 2% CHX is effective
in reducing total bacteria count, SM, lactobacilli [15] and
Enterococcus faecalis [16], but it does not achieve eradica-
tion. Similarly to CHX, alexidine (ALX) is a bisbiguanide
disinfectant, with faster bactericidal action [17]. ALX has
been previously used as a mouthwash [18] and contact
lens solution [19] and is being evaluated for possible use
in endodontics [20]. Both 1% and 2% ALX concentrations
have shown eradication of E. faecalis biofilm [21] and its
substantivity in dentin has been demonstrated [22]. Fur-
thermore, as compared with CHX, ALX shows lower tox-
icity when applied topically to corneal tissues in vivo [23].
Cetrimide (CTR) is a cationic surfactant, a quaternary am-
monium derivative, which has demonstrated its effective-
ness against gram-positive and gram-negative bacteria,
also showing antifungal activity [24]. Generally applied
as a topic antiseptic, it is not toxic at the concentrations
of use [25]. It is scarcely irritanting and it reduces the sur-
face tensión of liquids, favoring their entry into places of
difficult access, such as dentin tubules [26]. These features
justify its inclusión as a component of irrigating solutions
used in endodontics. At the concentrations used for root
canal irrigation, it has less toxicity than endodontic irri-
gants such as sodium hypochloride [27]. In addition to
eradicating E. faecalis biofilms in vitro [28] and ex vivo
[16], it exerts residual antimicrobial activity over time
[29]. As irrigating solutions in endodontics, 0.2% CTRhave shown their effectiveness [16]. It was recently shown
that 0.2% cetrimide provides longer substantivity than
0.2% chlorhexidine and nearly as long as that of 2% chlor-
hexidine in a dentin-volumetric model [29]. There is no
clear evidence to date of its effectiveness as a cavity disin-
fectant, but it has been effective in vitro, combined with
polyacrylic acid, in eliminating bacteria associated with
residual caries [30]. The aim of this study was therefore
to evaluate the antimicrobial activity of chlorhexidine,
cetrimide and alexidine against S. mutans biofilm, using a
dentin-volumetric test.
Methods and materials
Bacteria strain and antimicrobial solutions
The bacteria used in this study were S. mutans (SM)
(ATCC 25175) from the Spanish Type Culture Collec-
tion (CECT, Burgasot, Valencia). The bacteria were kept
in tubes containing Brain Heart Infusion (BHI) agar
(Scharlau Chemie SA, Barcelona, Spain), at 4°C for fur-
ther use in the experiments. From the subculture of SM,
a 1 McFarland standard suspension was prepared in BHI
broth and subsequently diluted to obtain a suspension of
approximately 6×107 colony-forming units per milliliter
(CFU/mL).
The solutions tested were 0.2% and 2% CHX (Guinama,
Alboraya, Spain), 0.2%, 0.5%, 1% and 2% ALX (Alexidine
dihydrochloride, Santa Cruz Biotechnology Inc., Heidelberg,
Germany) and 0.2% CTR (Sigma-Aldrich Chemie, Steinheim,
Germany).
Preparation of dentin blocks
The protocol was approved by the Ethics Committee of
the University of Granada, Spain. Twenty-seven uner-
upted extracted third human molars were stored in 0.1%
thymol solution at 4°C. In preparing the dentin blocks,
we followed the methodology described in a previous
article [16]. The teeth were sectioned, and the two apical
thirds of the roots were discarded, as was the occlusal
coronal enamel, leaving a flat coronal dentin surface.
This slice was cut into serial blocks. Four dentin blocks
without enamel/tooth were then adjusted using a cali-
brator and polished with 150-, 220-, and 600-grit silicon
carbide papers to obtain 2 × 2 × 1.2 mm (width × length ×
height) specimens. After sterilization, they were kept
in a sterile saline solution until use shortly thereafter.
The smear layer formed during preparation of the dentin
blocks was eliminated by submerging them in 37% ortho-
phosphoric acid for 15 seconds, after which they were
sterilized. The specimens were randomly assigned to the
different groups: 0.2% and 2% CHX; 0.2%, 0.5%, 1% and
2% ALX; 0.2% CTR; and one control group. Thus, each of
the four specimens per tooth was tested in a different
group. Two specimens per group, obtained from four
additional molars, were studied under scanning electron
Table 1 Antimicrobial activity against Streptococcus













2% CHX 0 61.000 6/12 96.57 (9.82)1,3
0.2% CHX 3.000 59.000 0/12 85.18 (10.60)2
2% ALX 0 19 10/12 99.99 (0.0033)1
1% ALX 0 72 8/12 99.99 (0.014)1
0.5% ALX 0 3.600 7/12 99.78 (0.58)1,3
0.2% ALX 0 4.700 5/12 99.56 (0.86)3
0.2% CTR 0 2.800 9/12 99.84 (0.45)1,3
CHX: chlorhexidine; ALX: alexidine; CTR: cetrimide.
E: eradication or 100% kill percentage with respect to the control.
Control values: Minimum: 60.000, maximum: 380.000, mean (standard
deviation): 178.333 (105.298).
*1, 2, 3The same number shows differences that are not statistically significant
determined by Student T test previously subjecting data to
Anscombe transformation.
p value of comparisons: 2% CHX vs 0.2% CHX: p < 0.001, 2% CHX vs 2% ALX:
p = 0.134, 2% CHX vs 1% ALX: p= 0.144, 2% CHX vs 0.5% ALX: p= 0.267, 2% CHX vs
0.2% ALX: p= 0.424, 2% CHX vs 0.2% CTR: p= 0.221, 0.2% CHX vs 2% ALX: p < 0.001,
0.2% CHX vs 1% ALX: p < 0.001, 0.2% CHX vs 0.5% ALX: p < 0.001, 0.2% CHX vs 0.2%
ALX: p < 0.001, 0.2% CHX vs 0.2% CTR: p < 0.001, 2% ALX vs 1% ALX: p = 0.174, 2%
ALX vs 0.5% ALX: p = 0.127, 2% ALX vs 0.2% ALX: p = 0.04, 2% ALX vs 0.2%CTR:
p = 0.212, 1% ALX vs 0.5% ALX: p = 0.156, 1% ALX vs 0.2% ALX: p = 0.04, 1% ALX vs
0.2% CTR: p = 0.275, 0.5% ALX vs 0.2% ALX: p = 0.413, 0.5% ALX vs 0.2% CTR:
p = 0.713, 0.2% ALX vs 0.2% CTR: p = 0.247.
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incubated in BHI for 24 hours at 37°C to ensure no bac-
terial contamination.
Biofilm antimicrobial activity test
The wells of 96-well microtiter plates (Nunclon Delta Surface;
Nunc, Roskilde, Denmark) were inoculated with 180 μL of
the initial bacterial suspension. Twelve wells were inocu-
lated with sterile BHI for the sterility control. The sterile
dentin blocks were submerged in the inoculated wells,
and they were incubated on a rocking table (Swing Sw 8
10000–0015; OVAN, Badalona, Spain) for 1 week at 37°C
in an anaerobic atmosphere. The BHI was refreshed daily
to ensure the growth of SM on the dentin blocks, and the
purity of the cultures was checked at regular intervals.
Dentin specimens with SM biofilm were rinsed with
120 μL 0.9% saline solution for 2 minutes to remove bac-
teria that were not strongly adhered to the biofilm.
The antimicrobial activity assay was performed in the
96-well microtiter plates with 100 μL of the antimicrobial
solutions per well. The saline rinsed specimens, dried with
sterile paper disks, were then placed in the wells in con-
tact with the disinfecting solutions for 1 minute. After
subjecting the dentin blocks to the disinfectant protocols,
sterile absorbent paper disks (IVD; Becton, Dickinson and
Company, Sparks, MD) were used to eliminate any excess
solution from the specimens. They were placed in Eppendorf
tubes with 200 μL BHI, vortexed for 10 seconds, and then
sonicated for 10 minutes to ensure biofilm recovery. Dis-
rupted biofilm cultures were diluted serially and plated for
viable cell counting.
Scanning electron microscopy
For SEM analysis, the specimens were washed in sterile
phosphate-buffered saline and then fixed with a 4% glutar-
aldehyde solution for 24 h. After that, biofilms were dehy-
drated in graded ethanol series (50, 70, 90, and 100%),
dried for 24 h, and sputter coated with gold-palladium.
The samples were then analyzed by SEM (Hitachi, S-510,
Japan) at 25 Kv.
Statistical analysis
Results of SM biofilm antimicrobial activity by different
protocols were expressed as the kill percentage of biofilm,
calculated as follows: (1 – [mean CFUantimicrobial solution/
mean CFUcontrol]) × 100). The term “eradication” was used
to denote the kill of 100% of the bacterial population.
To compare the efficacies of the different protocols, the
Student t test was used, previously subjecting data to the
Anscombe transformation.
Results
The negative controls showed no bacterial growth. The
results of the antimicrobial activity are shown in Table 1.All tested antimicrobial solutions obtained a high kill
percentage of SM biofilms with respect to the control.
Whereas 2% ALX and 0.2% CTR respectively showed
eradication in 10 and 9 of the 12 specimens, 0.2% CHX
did not produce eradication in any specimen. SEM images
showed a reduction of bacteria within the biofilms com-
pared with the control group (Figure 1). All the ALX con-
centrations tested, as well as 0.2% CTR, achieved kill
percentages higher than 99%, followed by 2% CHX, with
percentages above 96% (no significant statistical differ-
ences). The lowest kill percentage (85.18%), in this case
proving significantly different from the other groups, was
obtained with 0.2% CLX.
Discussion
Current management of deep carious lesions involves
minimally invasive techniques where only a partial caries
removal is performed [3]. These techniques show success
in clinical studies and microbiological reports examining
bacterial presence after such procedures have demon-
strated that the number of microorganisms is reduced
after incomplete carious dentin removal and tooth sealing
[5-9]. However, the persistence of viable bacteria in dentin
after these techniques has raised doubts regarding the
long-term effectiveness of treatment [31]. Streptococcus
mutans are cariogenic bacteria that may be found on sealed
carious dentin [2,6-9]. Using AP-PCR fingerprinting ana-
lysis, it has been reported that removing partially carious
Figure 1 Scanning electron microscopy images of Streptococcus mutans biofilm in the control group (A) and treated with 2%
chlorhexidine (B), 2% Alexidine (C) and 0.2% cetrimide (D).
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but not their cariogenic potential [9]. Therefore, treatment
of dentin with an antibacterial agent, before sealing, is use-
ful in eliminating the harmful effects of residual bacteria
or bacterial microleakage [10]. Accordingly, our objective
was to determine the ability of several antimicrobials in
controlling SM biofilm formed in dentin.
Dentin represents the primary substratum for bacterial
adhesion and biofilm formation [32], and its interaction
with antimicrobial solutions has been clearly shown [11].
As the carrier or biological unit of biofilm formations, we
chose a previously tested dentin-volumetric test [16,22,29]
in which specimens can be easily size standardized, in-
fected, and handled. At least four specimens may be
obtained from each molar, which permits their assign-
ment to different groups, reducing the inherent variability
of the sample.
To control dentin infection, one desirable property of
antimicrobial agents is their effectiveness against cariogenic
bacteria growing as biofilm. In the past decade, antimicro-
bial agents have been incorporated into dental materials to
lend them antimicrobial activity [33,34]. The incorporation
of CHX and/or CTR into glass ionomer cement (GIC) is
known to confer it with beneficial antibacterial properties
[34]. It was recently shown that the incorporation of
CHX, CTR or both into AH Plus, an endodontic cement,
improves antibacterial action against E. faecalis [35]. Using
an Agar diffusion test, Nikihl et al. found that the additionof 2% CHX to Biodentine enhanced its antibacterial
activity against SM, S. aureus, E. faecalis and C. albicans
[36], whereas Korkmaz et al. showed that incorporating a
5%CHX-CTR mixture into conventional dental luting ce-
ment may provide greater antibacterial protection against
SM and Lactobacillus [37].
For this study we selected three antimicrobial agents.
CHX was included because it is considered the gold stand-
ard, functioning as a potent metalloproteinase inhibitor
[38] while capable of reducing bacterial load substantially
[15,16]; yet it has not proven effective in eradicating biofilm
in dentin [15], or in vitro, even at concentrations as high as
4% during one minute of exposure [28]. Our results con-
firmed the well known concentration-effectiveness of CLX
and the need to use concentrations higher than the usual
one (2%) to disinfect dentin. Moreover, despite the par-
ticular sensitivity of SM to CLX [16] in dentin, 0.2% CLX
did not manage to eradicate the biofilm of any specimen,
and the percentage of reduction (85%) was lower than
with the other solutions. These results, to be expected,
show that this concentration is not adequate for cavity
disinfection.
The lowest kill percentages in our study were seen with
CHX and the 2% CHX solution; but these did not reach
statistically significant differences with respect to ALX and
CTR. Six specimens showed eradication with 2% CHX, a
value between those achieved with ALX at concentrations
that were five (0.2% ALX) to ten times lower (0.5% ALX),
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should stress that the form of bacteria in biofilms makes
it less sensitive to antimicrobial agents, and that CHX can
bind to proteins of the extracellular matrix of the biofilm,
reducing its activity [39]. Moreover, dentin can inactivate
or weaken the antimicrobial effect of CHX [32].
To the best of our knowledge, no studies have tested
ALX as a cavity disinfectant. Nevertheless, 1% and 2% of
ALX used for 1 minute provide longer antimicrobial sub-
stantivity against E. faecalis in dentin [22]. We found that
no concentration could completely eradicate SM in all the
specimens, while concentrations of 2% and 1% ALX ob-
tained the highest kill reduction percentage (99.99%) and
eradication, respectively, in 10 and 8 of the twelve speci-
mens, giving statistically significant differences from 0.2%
ALX (99.56%). Intermediate values were obtained with
0.5% ALX (99.78%). The good results with ALX in an ex-
posure time of 1 minute might be attributed in part to the
speed of its bactericidal action, given the higher affinity of
ALX to lipopolysaccharide and lipoteichoic acids [40].
These results show that ALX can be an effective cavity
disinfectant, particularly when techniques of partial caries
removal are involved.
Cetrimide, with demonstrated effectiveness in eradicat-
ing E. faecalis biofilms [16] and residual antimicrobial
activity [29], obtained results similar to 1% and 2% ALX.
In a study using the same methodology but with E. faecalis
biofilms, this antimicrobial solution succeeded in eradicat-
ing biofilm on all specimens [16]. The reduced effectiveness
of CTR on SM could depend on the special characteristics
of these bacteria. As a surfactant with antimicrobial prop-
erties which can weaken the cohesive forces of the biofilm,
CTR disrupts the extracellular polysaccharide matrix [41].
The surfactant and antimicrobial properties make it effect-
ive against E. faecalis biofilms. Unlike E. faecalis however,
SM can form a large quantity of extracellular polysaccha-
rides [42], which afford this bacteria a certain ecological
advantage.
We conclude that 2% and 1% ALX, as well as 0.2%
CTR, achieved eradication of SM biofilm in most of the
specimens of our study. In a clinical situation these anti-
microbial solutions could be proposed as an alternative
to CHX, for therapeutic cavity disinfection when applied
for one minute. Given the diversity of the microbiota in
carious dentin, and in view of the results described here,
future studies should aim to evaluate the effect of differ-
ent antimicrobial combinations for the control of bac-
teria involved in dentin caries.
Competing interests
The authors declare no potential conflicts of interest with respect to the
authorship and/or publication of this article.
Authors’ contribution
The study was designed by authors PB, MRL and CMFL, and executed by
MRL, MTAM. PC and BA participated in the study design and carried outbiofilm and hard tissue preparation. The statistical analysis was done by PB
and the article was written by MRL and CMFL and PB. This study is part of
the doctoral thesis of BA. The acknowledged person has seen the text and
given permission to be named. All authors read and approved the final
manuscript.Acknowledgments
The authors deny any conflicts of interest related to this study. The authors
thank Francisca Castillo Pérez for her technical assistance. This study was
supported by Research Group CTS-167 of the Junta de Andalucía, Spain.
Author details
1Department of Paediatric Dentistry, School of Dentistry, University of
Granada, Campus de Cartuja, Colegio Máximo s/n, Granada, Spain.
2Department of Dental Pathology and Therapeutics, School of Dentistry,
University of Granada, Campus de Cartuja, Colegio Máximo s/n, Granada,
Spain. 3Department of Microbiology, School of Dentistry, University of
Granada, Granada, Spain. 4University of Granada, Granada, Spain.
5Department of Preventive Dentistry, School of Dentistry, University of
Granada, Campus de Cartuja, Colegio Máximo s/n, Granada, Spain.
Received: 9 June 2014 Accepted: 3 August 2014
Published: 20 August 2014References
1. Aas JA, Griffen AL, Dardis SR, Lee AM, Olsen I, Dewhirst FE, Leys EJ, Paster
BJ: Bacteria of dental caries in primary and permanent teeth in children
and young adults. J Clin Microbiol 2008, 46:1407–1417.
2. Ayna B, Celenk S, Atakul F, Sezgin B, Ozekinci T: Evaluation of clinical and
microbiological features of deep carious lesions in primary molars. J Dent
Child (Chic) 2003, 70:15–18.
3. Ricketts DN, Kidd EA, Innes N, Clarkson J: Complete or ultraconservative
removal of decayed tissue in unfilled teeth. Cochrane Database Syst Rev
2006, 19:CD003808.
4. Kidd EAM: How clean must a cavity be before restoration? Caries Res
2004, 38:305–313.
5. Bjørndal L, Larsen T: Changes in the cultivable flora in deep carious
lesions following a stepwise excavation procedure. Caries Res 2000,
34:502–508.
6. Orhan AI, Oz FT, Ozcelik B, Orhan K: A clinical and microbiological
comparative study of deep carious lesion treatment in deciduous and
young permanent molars. Clin Oral Invest 2008, 12:69–78.
7. Lula EC, Monteiro-Neto V, Alves CM, Ribeiro CC: Microbiological analysis
after complete or partial removal of carious dentin in primary teeth:
a randomized clinical trial. Caries Res 2009, 43:354–358.
8. Duque C, Negrini Tde C, Sacono NT, Spolidorio DM, de Souza Costa CA,
Hebling J: Clinical and microbiological performance of resin-modified
glass-ionomer liners after incomplete dentine caries removal. Clin Oral
Invest 2009, 13:465–471.
9. Damé-Teixeira N, Arthur RA, Parolo CC, Maltz M: Genotypic Diversity and
Virulence Traits of Streptococcus mutans Isolated from Carious Dentin
after Partial Caries Removal and Sealing. ScientificWorldJournal 2014,
21:165201. doi:10.1155/2014/165201. eCollection 2014.
10. Ersin NK, Uzel A, Aykut A, Candan U: Inhibition of cultivable bacteria by
chlorhexidine treatment of dentin lesions treated with the ART
technique. Caries Res 2006, 40:172–177.
11. Carrilho MR, Carvalho RM, Sousa EN, Nicolau J, Breschi L, Mazzoni A,
Tjäderhane L, Tay FR, Agee K, Pashley DH: Substantivity of chlorhexidine to
human dentin. Dent Mater 2010, 26:779–785.
12. Rosenberg L, Atar M, Daronch M, Honig A, Chey M, Funny MD, Cruz L:
Prospective study of indirect pulp treatment in primary molars using
resin-modified glass ionomer and 2% chlorhexidine gluconate:a
12 month follow-up. Pediatr Dent 2013, 35:13–17.
13. Järvinen H, Pienihäkkinen K, Huovinen P, Tenovuo J: Susceptibility of
Streptococcus mutans and Streptococcus sobrinus to antimicrobial agents
after short-term oral chlorhexidine treatments. Eur J Oral Sci 1995,
103:32–35.
14. Mohammadi Z, Abbott PV: The properties and applications of
chlorhexidine in endodontics. Int Endod J 2009, 42:288–302.
Ruiz-Linares et al. Annals of Clinical Microbiology and Antimicrobials 2014, 13:41 Page 6 of 6
http://www.ann-clinmicrob.com/content/13/1/4115. Borges FC, de Melo MS, Lima JM, Zanin IJ, Rodrigues LA: Antimicrobial
effect of chlorhexidine digluconate in dentin: in vitro and in situ study.
J Conserv Dent 2012, 15:22–26.
16. Baca P, Junco P, Arias-Moliz MT, González-Rodríguez MP, Ferrer-Luque CM:
Residual and antimicrobial activity of final irrigation protocols on Enterococcus
faecalis biofilm in dentin. J Endod 2011, 37:363–366.
17. McDonnell G, Russell AD: Antiseptics and disinfectants: activity, action,
and resistance. Clin Microbiol Rev 1999, 12:147–179.
18. Roberts WR, Addy M: Comparison of the bisbiguanide antiseptics
alexidine and chlorhexidine: I. Effect on plaque accumulation and
salivary bacteria. J Clin Periodontol 1981, 8:213–219.
19. Yanai R, Ueda K, Nishida T, Toyohara M, Mori O: Effects of tonicity-adjusting
and surfactant agents on the antimicrobial activity of alexidine. Eye Contact
Lens 2011, 37:57–60.
20. Kim HS, Woo Chang S, Baek SH, Han SH, Lee Y, Zhu Q, Kum KY:
Antimicrobial effect of alexidine and chlorhexidine against Enterococcus
faecalis infection. Int J Oral Sci 2013, 5:26–31.
21. Silveira LF, Baca P, Arias-Moliz MT, Rodríguez-Archilla A, Ferrer-Luque CM:
Antimicrobial activity of alexidine alone and associated with N-
acetylcysteine against Enterococcus faecalis biofilm. Int J Oral Sci 2013,
5:146–149.
22. Barrios R, Ferrer-Luque CM, Arias-Moliz MT, Ruiz-Linares M, Bravo M, Baca P:
Antimicrobial substantivity of alexidine and chlorhexidine in dentin.
J Endod 2013, 39:1413–1415.
23. Alizadeh H, Neelam S, Cavanagh HD: Amoebicidal activities of alexidine
against 3 pathogenic strains of acanthamoeba. Eye Contact Lens 2009,
35:1–5.
24. Vieira DB, Carmona-Ribeiro AM: Cationic lipids and surfactants as antifungal
agents: mode of action. J Antimicrob Chemother 2006, 58:760–767.
25. Cloete TE, Jacob L, Brozel VS: The chemical control of biofouling in
industrial water systems. Biodegradation 1998, 9:23–37.
26. Giardino L, Ambu E, Becce C, Rimondini L, Morra M: Surface tension
comparison of four common root canal irrigants and two new irrigants
containing antibiotic. J Endod 2006, 32:1091–1093.
27. Onçağ O, Hoşgör M, Hilmioğlu S, Zekioğlu O, Eronat C, Burhanoğlu D:
Comparison of antibacterial and toxic effects of various root canal
irrigants. Int Endod J 2003, 36:423–432.
28. Arias-Moliz MT, Ferrer-Luque CM, González-Rodríguez MP, Valderrama MJ,
Baca P: Eradication of Enterococcus faecalis biofilms by cetrimide and
chlorhexidine. J Endod 2010, 36:87–90.
29. Baca P, Junco P, Arias-Moliz MT, Castillo F, Rodríguez-Archilla A, Ferrer-
Luque CM: Antimicrobial substantivity over time of chlorhexidine and
cetrimide. J Endod 2012, 38:927–930.
30. Botelho MG: The antimicrobial activity of a dentin conditioner combined
with antibacterial agents. Oper Dent 2005, 30:75–82.
31. Weerheijm KL, Kreulen CM, de Soet JJ, Groen HJ, van Amerongen WE:
Bacterial counts in carious dentine under restorations: 2-year in vivo
effects. Caries Res 1999, 33:130–134.
32. Haapasalo M, Qian W, Portenier I, Waltimo T: Effects of dentin on the
antimicrobial properties of endodontic medicaments. J Endod 2007,
33:917–925.
33. Imazato S: Antibacterial properties of resin composites and dentin
bonding systems. Dent Mater 2003, 19:449–457.
34. Tüzüner T, Kuşgöz A, Er K, Taşdemir T, Buruk K, Kemer B: Antibacterial
activity and physical properties of conventional glass-ionomer cements
containing chlorhexidine diacetate/cetrimide mixtures. J Esthet Restor
Dent 2011, 23:46–55.
35. Bailón-Sánchez ME, Baca P, Ruiz-Linares M, Ferrer-Luque CM: Antibacterial
and anti-biofilm activity of AH Plus with chlorhexidine and cetrimide.
J Endod 2014, 40:977–981.
36. Nikhil V, Madan M, Agarwal C, Suri N: Effect of addition of 2%
chlorhexidine or 10% doxycycline on antimicrobial activity of
biodentine. J Conserv Dent 2014, 17:271–275.
37. Korkmaz FM, Tüzüner T, Baygin O, Buruk CK, Durkan R, Bagis B: Antibacterial
activity, surface roughness, flexural strength, and solubility of
conventional luting cements containing chlorhexidine diacetate/
cetrimide mixtures. J Prosthet Dent 2013, 110:107–115.
38. Gendron R, Grenier D, Sorsa T, Mayrand D: Inhibition of theactivities of
matrix metalloproteinases 2, 8 and 9 by chlorhexidine. Clin Diagn Lab
Immunol 1999, 6:437–439.39. Kara D, Luppens SB, van Marle J, Ozok R, ten Cate JM: Microestructural
differences between single-species and dual-species biofilm of
Streptococcus mutans and Veionella parvula, before and after exposure to
chlorhexidine. FEMS Microbiology Lett 2007, 271:90–97.
40. Zorko M, Jerala R: Alexidine and Chlorhexidine bind to lipopolysaccharide
and lipoteichoic acid and prevent cell activation by antibiotics. J Antimicrob
Chemother 2008, 62:730–737.
41. Simoes M, Pereira MO, Vieira MJ: Effects of mechanical stress on biofilms
challenged by different chemical. Water Res 2005, 39:5142–5152.
42. Bowen WH, Koo H: Biology of Streptococcus mutans-derived
glucosyltransferases: role in extracellular matrix formation of cariogenic
biofilms. Caries Res 2011, 45:69–86.
doi:10.1186/s12941-014-0041-5
Cite this article as: Ruiz-Linares et al.: Antimicrobial activity of alexidine,
chlorhexidine and cetrimide against Streptococcus mutans biofilm.
Annals of Clinical Microbiology and Antimicrobials 2014 13:41.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
